Skip to main content
Equibles

NVS · Novartis AG · Metrics

Track NVS — free

Use NVS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NVS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$160.50 +0.25 (+0.16%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$303.12B
Shares
1.89B
Volume · Nov 13 1.42M Avg daily vol (3M) 2.11M

NVS metrics

80 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$160.50
Market cap
$303.12B

Price action

23 metrics
Price change (1W)
-1.3%
Price change (30D)
+6.7%
Price change (3M)
+6.4%
Price change (6M)
+8.4%
Price change (YTD)
+16.4%
Price change (1Y)
+21.7%
Trailing year
Price change (5Y)
+94.6%
52-week high
$168.62
52-week low
$124.36
Change from 52-week high
-4.8%
Change from 52-week low
+29.1%
Annualized volatility
27.2%
Annualized volatility (3M)
37.9%
Implied volatility (30D)
26.4%
IV rank (1Y)
52.3
IV percentile (1Y)
68.4
Beta
0.4
RSI (14D)
58.5
Price vs SMA 50
+7.6%
Price vs SMA 200
+5.2%
Avg volume (3M)
2.11M
Relative volume
0.7
Average dollar volume
$317.98M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
1.89B

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
7.3
reciprocal yield 13.7%
FCF yield
5.5%
TTM · current market cap
Buyback yield
2.3%
P / FCF
18.1
reciprocal yield 5.5%
P / operating cash flow
16.5
reciprocal yield 6.1%
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
3.0%
Trailing 12 months
Payout ratio
—
Shareholder yield
2.3%
Dividend / share (TTM)
$4.77
Dividend growth YoY
+19.5%
Dividend growth streak
3
Last ex-dividend
2026-03-11

Earnings calendar

2 metrics
Next earnings
2027-02-03
Last earnings
2026-10-27

Profitability

9 metrics
Gross margin
78.8%
Operating margin
32.4%
Trailing 12 months
Net margin
25.6%
Gross profit (TTM)
$42.37B
Operating profit (TTM)
$17.10B
Net income (TTM)
$12.76B
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
17.9%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$24.18

Growth

11 metrics
Revenue growth YoY
+8.4%
Year over year
Net income growth YoY
-19.2%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
-17.0%
Shares change YoY
-3.4%
Year over year · fewer shares
Revenue CAGR (3Y)
+8.9%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
+31.1%
EPS CAGR (5Y)
+15.2%
FCF CAGR (3Y)
+9.7%
FCF CAGR (5Y)
+7.3%

Quality

14 metrics
Return on equity
30.7%
Return on assets
10.5%
Debt / equity
—
Current ratio
0.9
EBITDA (TTM)
—
Free cash flow (TTM)
$16.76B
Quick ratio
0.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$7.62B
Total assets
$122.03B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$18.39B
Capital expenditures (TTM)
$1.63B
R&D (TTM)
$11.69B
SG&A (TTM)
—
Stock compensation (TTM)
$1.14B
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
1,631
13F filer change QoQ
+18
Institutional ownership
7.6%
Conviction holders (share of 13F filers)
0.6%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-3.2%
Holder tenure
21.5
Price vs estimated holder cost
+20.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.2%
Latest settlement · 1.9 days to cover
Days to cover
1.9d
Short-squeeze score
45 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1114448 CUSIP 66987V109 13F (30d) 1276 filings 1161 filers Visit website Investor relations